• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Oct 13
8:00 am - 9:00 am EDT

Member Forum: Technology Solutions for PALS

Oct 13
6:00 pm - 7:00 pm EDT

Member Forum: Technology Solutions for PALS

Oct 15
9:00 am - 10:00 am EDT

Webinar: The Use of AI in ALS/MND

Oct 17
2:00 pm - 3:00 pm EDT

ALS Association Webinar: So, What’s Next? Understanding the Decisions along an ALS Journey

Oct 21
7:00 am - 8:30 am EDT

Member Roundtable: Defining Rights in the Genetics Era of ALS/MND

View Calendar

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Jon Newsome, USA

    Jon Newsome, USA

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Ian Gale, Australia

    Ian Gale, Australia

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Daniela Maria Daverio, Argentina

    Daniela Maria Daverio, Argentina

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Alex, Argentina

    Alex, Argentina

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Jon Newsome, USA

    Jon Newsome, USA

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Jack Buzby, USA

    Jack Buzby, USA

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Steve

    Steve

  • Mike Cels, Canada

    Mike Cels, Canada

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Jean Waters, UK

    Jean Waters, UK

  • Liam Dwyer, England

    Liam Dwyer, England

  • John Sweeney, USA

    John Sweeney, USA

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • David Watson, Scotland

    David Watson, Scotland

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Sally Pauls, USA

    Sally Pauls, USA

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login